The NCCN guidelines recommend genetic testing for BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11 and TP53 in women aged ≤50 years with a personal history of breast cancer. This evidence concerns the gene BRCA2 and breast carcinoma.